Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2018
Peer-review started: October 21, 2023
First decision: January 25, 2024
Revised: January 31, 2024
Accepted: March 8, 2024
Article in press: March 8, 2024
Published online: May 15, 2024
Processing time: 201 Days and 12.2 Hours
Gastric cancer (GC) is a common malignancy of the digestive system. Ferroptosis or iron-dependent programmed cell death, has been linked to GC, although there has been little research on the link between Helicobacter pylori (H. pylori) infection-related GC and ferroptosis.
This study investigated the coregulated differentially expressed genes (co-DEGs) among ferroptosis-related genes (FRGs) in H. pylori infection-related GCs and investigated the relationship between the expression of these co-DEGs and clinical prognosis.
This study developed a prognostic model for GC based on co-DEGs among FRGs. Gene expression profiles from GC patients and H. pylori-associated GC patients were analyzed.
Gene expression profiles of GC patients and those with H. pylori-associated GC were obtained from the cancer genome atlas and gene expression omnibus (GEO) databases. The FRGs were acquired from the FerrDb database. A ferroptosis-related gene prognostic index (FRGPI) was created using least absolute shrinkage and selection operator–Cox regression. The predictive ability of the FRGPI was validated in the GEO cohort. Finally, we verified the expression of the hub genes and the activity of the ferroptosis inducer FIN56 in GC cell lines and tissues.
The four hub genes (NOX4, MTCH1, GABARAPL2, and SLC2A3) accurately predicted GC and H. pylori-associated GC. The FRGPI based on the hub genes independently predicted patient survival. High-risk GC patients had notably worse overall survival. The FRGPI was found to be a significant predictor of GC prognosis and correlated with disease progression. The expression of immune checkpoint proteins increased in the high-risk group. Hub genes were highly overexpressed in GC cell lines and tissues, primarily at the cell membrane. The ferroptosis inducer FIN56 inhibited GC cell proliferation in a dose-dependent manner.
The predictive model provides an accurate prognosis for GC patients and helps evaluate immunotherapy efficacy.
The mechanism of the hub gene in the occurrence and development of GC was studied, and its effect on iron death in GC cells was analyzed.